FIELD: medicine.
SUBSTANCE: invention relates to cardiology, functional diagnostics and oncology. Echocardiographic diagnostics is used to determine an indexed volume of the left atrium (LA) using the Mosteller formula. If the indexed volume of the LA increases to 34.0 cm/m2 or more compared to the values of the indexed LA volume in the given patient, determined initially, before the onset of the cardiotoxic chemo- or targeted therapy, cardiotoxicity and high risk of lethal outcome are predicted.
EFFECT: method enables higher accuracy of diagnosing cardiotoxicity at the stage preceding the onset of clinical manifestations by using an easily accessible and reproducible method.
1 cl, 2 dwg, 4 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING SUBCLINICAL CARDIOTOXICITY OF CHEMO- AND TARGETED THERAPY USING ECHOCARDIOGRAPHIC DIAGNOSTICS | 2022 |
|
RU2815813C1 |
| METHOD FOR PREVENTING ANTHRACYCLINE CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER | 2014 |
|
RU2546399C1 |
| METHOD FOR THE COMBINED TREATMENT OF CHRONIC HEART FAILURE AGAINST THE BACKGROUND OF TYPE 2 DIABETES MELLITUS | 2022 |
|
RU2785744C1 |
| METHOD FOR PREDICTION OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN WOMEN WITH BREAST CANCER | 2019 |
|
RU2714683C1 |
| METHOD FOR PREDICTION OF CUMMULATIVE CARDIAC TOXICITY OF CHEMOTHERAPEUTIC PREPARATIONS | 2012 |
|
RU2510240C2 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF CARDIOTOXICITY IN PATIENTS WITH HER2 POSITIVE BREAST CANCER OF INITIALLY LOW / MODERATE CARDIOVASCULAR RISK RECEIVING A TARGETED THERAPY WITH TRASTUZUMAB AFTER ANTHRACYCLINE-CONTAINING CHEMOTHERAPY | 2020 |
|
RU2741371C1 |
| METHOD FOR PERSONALIZED SELECTION OF PATIENTS WITH ANTHRACYCLINE-INDUCED CARDIOMYOPATHY AFTER POLYCHEMOTHERAPY OF BREAST CANCER FOR EFFECTIVE TREATMENT WITH CARVEDILOL | 2021 |
|
RU2778612C1 |
| METHOD FOR PREDICTING PROGRESSION OF ANTHRACYCLINE-INDUCED CHRONIC HEART FAILURE IN PATIENTS WITH BREAST CANCER WITHIN 24 MONTHS | 2022 |
|
RU2793672C1 |
| PREDICTION METHOD OF HIGH-GRADE VENTRICULAR ARRHYTHMIA IN PATIENTS WITH CHRONIC HEART FAILURE AND PRESERVED LEFT VENTRICULAR EJECTION FRACTION | 2017 |
|
RU2645958C1 |
| METHOD FOR PREDICTING DEVELOPMENT OF CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER WITHIN 12 MONTHS AFTER CHEMOTHERAPY WITH ANTRACYCLIC DRUGS | 2018 |
|
RU2680139C1 |
